BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Life Sciences Leader Polaris Announces Key Additions to its Global Executive Team

  Today, Polaris announced the addition of three senior executives to the firm. Chrisoula Nikidis has been hired as the Canadian Head of Compliance and Ethics Solutions.

  February 6, 2018

   · 

  5 min read
• Business

  Eclipse’s Rapid Growth Leads to New Management

  Eclipse is proud to announce the promotion of Michael O’Brien to the position of Vice President of Sales for the United States.

  February 6, 2018

   · 

  2 min read
• Biotech Beach

  Viking Announces Closing of Public Offering of Common Stock

  The gross proceeds to Viking from this offering are approximately $63.3M, before deducting underwriting discounts and commissions and other estimated offering expenses.

  February 6, 2018

   · 

  5 min read
• Policy

  TraceLink Dismisses Litigation Claims Against Healthcare Distribution Alliance (HDA)

  TraceLink agreed to the dismissal as they have resolved the misunderstandings that led to their dispute.

  February 6, 2018

   · 

  3 min read
• Biotech Bay

  Gilead Sciences Announces 10 Percent Increase in First Quarter 2018 Dividend

  The dividend increase will result in a quarterly dividend of $0.57 per share of common stock.

  February 6, 2018

   · 

  1 min read
• Biotech Bay

  Veeva to Release Fiscal 2018 Fourth Quarter and Full Year Results on February 27, 2018

  Veeva will host a conference call and webcast that day at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results.

  February 6, 2018

   · 

  1 min read
• QIAGEN Launches Predictive Therascreen Pitx2 Test in Europe to Guide Treatment in High-Risk Breast Cancer

  QIAGEN announced the European launch of its novel therascreen PITX2 RGQ PCR Kit, the first clinically validated DNA methylation assay that helps predict the response of certain high-risk breast cancer patients to anthracycline-based chemotherapy.

  February 6, 2018

   · 

  2 min read
• Genetown

  Verastem Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  Verastem today announced the grant of stock options to six new employees to purchase an aggregate of 219,000 shares of Verastem’s common stock.

  February 6, 2018

   · 

  2 min read
• Business

  Seattle Genetics Reports Fourth Quarter and Year 2017 Financial Results

  tSeattle Genetics today reported financial results for the fourth quarter and year ended December 31, 2017.

  February 6, 2018

   · 

  19 min read
• Business

  Gilead Sciences Announces Fourth Quarter and Full Year 2017 Financial Results

  Total revenues for the fourth quarter of 2017 were $5.9 billion compared to $7.3 billion for the same period in 2016.

  February 6, 2018

   · 

  29 min read